Mechanistic Activity and Development History of CDK 4/6 Inhibitors

Mechanistic Activity and Development History of CDK 4/6 Inhibitors

ER-Positive Breast Cancer: What's New in Treatment and Research at MBC Patient Forum 2019Подробнее

ER-Positive Breast Cancer: What's New in Treatment and Research at MBC Patient Forum 2019

Aging and Cancer: NCI Director Dr. Norman Sharpless at Albert Einstein College of MedicineПодробнее

Aging and Cancer: NCI Director Dr. Norman Sharpless at Albert Einstein College of Medicine

Expert Perspectives: Rationale for CDK 4/6 Inhibition in Breast CancerПодробнее

Expert Perspectives: Rationale for CDK 4/6 Inhibition in Breast Cancer

The Biological Rationale for CDK4/6 InhibitorsПодробнее

The Biological Rationale for CDK4/6 Inhibitors

Space Radiation and CataractsПодробнее

Space Radiation and Cataracts

События